eNOS translocation but not eNOS phosphorylation is dependent on intracellular Ca 2+ in human atrial myocardium

American Journal of Physiology - Cell Physiology

Volumn 290, Issue 5, 2006, Pages

  Pott, Christian ^b   Steinritz, Dirk ^a   Bölck, Birgit ^b   Mehlhorn, Uwe ^b   Brixius, Klara ^a   Schwinger, Robert H G ^b,c   Bloch, Wilhelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Clinic II of Internal Medicine and Cardiology   (Germany)

Author keywords

3 adrenoceptor; BRL 37344; Ca 2+ regulation; Cardiomyocyte; Heart

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; ADENYLATE CYCLASE ACTIVATOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; CHELATING AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FLUORESCEIN; FORSKOLIN; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; SERINE;

ADULT; ANTIBODY LABELING; ARTERY BYPASS; ARTICLE; BYPASS SURGERY; CALCIUM CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; GENE TRANSLOCATION; HEART ATRIUM MUSCLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; WESTERN BLOTTING;

CALCIUM; CELLS, CULTURED; HEART ATRIA; HUMANS; INTRACELLULAR FLUID; MYOCARDIUM; MYOCYTES, CARDIAC; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTEIN TRANSPORT;

EID: 33646420374     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00005.2005     Document Type: Article

References (40)

1. 3 and atypical β-adrenoceptors. Med Res Rev 13: 663-729, 1993.
2. Balligand JL, Kobzik L, Han X, Kaye DM, Belhassen L, O'Hara DS, Kelly RA, Smith TW, and Michel T. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 270: 14582-14586, 1995.
3. Bauer PM, Fulton D, Boo YC, Sorescu GP, Kemp BE, Jo H, and Sessa WC. Compensatory phosphorylation and protein-protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric-oxide synthase. J Biol Chem 278: 14841-14849, 2003.
4. Beuckelmann DJ, Näbauer M, and Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 85: 1046-1055, 1992.
5. Bloch W, Mehlhorn U, Krahwinkel A, Reiner M, Dittrich M, Schmidt A, and Addicks K. Ischemia increases detectable endothelial nitric oxide synthase in rat and human myocardium. Nitric Oxide 5: 317-333, 2001.
6. 635 by a protein kinase A-dependent mechanism. Am J Physiol Heart Circ Physiol 283: H1819-H1828, 2002.
7. Boo YC, Sorescu GP, Bauer PM, Fulton D, Kemp BE, Harrison DG, Sessa WC, and Jo H. Endothelial NO synthase phosphorylated at SER635 produces NO without requiring intracellular calcium increase. Free Radic Biol Med 35: 729-741, 2003.
8. Brady AJ, Warren JB, Poole-Wilson PA, Williams TJ, and Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol Heart Circ Physiol 265: H176-H182, 1993.
9. Bredt DS and Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682-685, 1990.
10. 3-adrenoceptor-induced eNOS activation in right atrial and left ventricular human myocardium. Br J Pharmacol 143: 1014-1022, 2004.
11. 2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells. J Biol Chem 276: 32663-32669, 2001.
12. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, and Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601-605, 1999.
13. Drew BG, Fidge NH, Gallon-Beaumier G, Kemp BE, and Kingwell BA. High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc Natl Acad Sci USA 101: 6999-7004, 2004.
14. Fleming I, Bauersachs J, and Busse R. Calcium-dependent and calciumindependent activation of the endothelial NO synthase. J Vasc Res 34: 165-174, 1997.
15. 2+/calmodulin- dependent endothelial nitric oxide synthase activity. Circ Res 88: E68-E75, 2001.
16. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, and Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597-601, 1999.
17. Gauthier C, Leblais V, Kobzik L, Trochu JN, Khandoudi N, Bril A, Balligand JL, and Le Marec H. The negative inotropic effect of β3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest 102: 1377-1384, 1998.
18. 3-adrenoceptor in the human heart. J Clin Invest 98: 556-562, 1996.
19. Heymes C, Vanderheyden M, Bronzwaer JGF, Shah AM, and Paulus WJ. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation 99: 3009-3016, 1999.
20. Igarashi J, Thatte HS, Prabhakar P, Golan DE, and Michel T. Calcium-independent activation of endothelial nitric oxide synthase by ceramide. Proc Natl Acad Sci USA 96: 12583-12588, 1999.
21. + exchange: structure, regulation, and its role in heart disease. Circ Res 85: 777-786, 1999.
22. Keaney JF Jr, Hare JM, Balligand JL, Loscalzo J, Smith TW, and Colucci WS. Inhibition of nitric oxide synthase augments myocardial contractile responses to β-adrenergic stimulation. Am J Physiol Heart Circ Physiol 271: H2646-H2652, 1996.
23. Kelly RA, Balligand JL, and Smith TW. Nitric oxide and cardiac function. Circ Res 79: 363-380, 1996.
24. Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, Hirata Y, and Nagano T. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem 70: 2446-2453, 1998.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
26. Lefer AM and Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 32: 743-751, 1996.
27. Liu P, Xu B, Forman LJ, Carsia R, and Hock CE. L-NAME enhances microcirculatory congestion and cardiomyocyte apoptosis during myocardial ischemia-reperfusion in rats. Shock 17: 185-192, 2002.
28. Loke KE, Laycock SK, Mital S, Wolin MS, Bernstein R, Oz M, Addonizio L, Kaley G, and Hintze TH. Nitric oxide modulates mitochondrial respiration in failing human heart. Circulation 100: 1291-1297, 1999.
29. Massion PB, Feron O, Dessy C, and Balligand JL. Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 93: 388-398, 2003.
30. Michel JB, Feron O, Sase K, Prabhakar P, and Michel T. Caveolin versus calmodulin: counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem 272: 25907-25912, 1997.
31. Michell BJ, Harris MB, Chen Z, Ju H, Venema VJ, Blackstone MA, Huang W, Venema RC, and Kemp BE. Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635. J Biol Chem 277: 42344-42351, 2002.
32. 1179. J Biol Chem 276: 30392-30398, 2001.
33. 2+ release in cardiomyocytes. Nat Cell Biol 3: 867-873, 2001.
34. 3-adrenoceptors in human atrial myocardium. Br J Pharmacol 138: 521-529, 2003.
35. Reiner M, Bloch W, and Addicks K. Functional interaction of caveolin-1 and eNOS in myocardial capillary endothelium revealed by immunoelectron microscopy. J Histochem Cytochem 49: 1605-1610, 2001.
36. Schwinger RH, Böhm M, and Erdmann E. Evidence against spare or uncoupled β-adrenoceptors in the human heart. Am Heart J 119: 899-904, 1990.
37. Schwinger RH, Böhm M, Pieske B, and Erdmann E. Different β-adrenoceptor-effector coupling in human ventricular and atrial myocardium. Eur J Clin Invest 21: 443-451, 1991.
38. 2-adrenoceptors in the failing and nonfailing human heart. Eur J Clin Pharmacol 42: 607-611, 1992.
39. Su Z, Blazing MA, Fan D, and George SE. The calmodulin-nitric oxide synthase interaction: critical role of the calmodulin latch domain in enzyme activation. J Biol Chem 270: 29117-29122, 1995.
40. Takahashi S and Mendelsohn ME. Synergistic activation of endothelial nitric-oxide synthase (eNOS) by HSP90 and Akt: calcium-independent eNOS activation involves formation of an HSP90-Akt-CaM-bound eNOS complex. J Biol Chem 278: 30821-30827, 2003.